Study: Cefazolin Better Than Vancomycin for Infection Control in Dialysis Patients
A recent study published in the Journal of the American Society of Nephrology suggests cefazolin may be better at controlling infections than vancomycin in dialysis patients.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Researchers compared the effectiveness of various antibiotics at preventing hospitalization and death from bloodstream infection. They reviewed more than 500,000 blood culture results from their chronic kidney disease database, looking for methicillin-sensitive strains of S. aureus bloodstream infection. They also identified when physicians used vancomycin or cefazolin to treat these infections.
The researchers found patients treated with cefazolin experienced a 38 percent lower rate of hospitalization and death from bloodstream infections compared to patients treated with vancomycin. Cefazolin-treated patients also had a 48 percent lower rate of sepsis.
More Articles on Infection Control:
Unintended Patient Safety Consequences of Nonclinical Decisions: 2 Cases
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the free Becker's Operating Room Clinical Quality & Infection Control
E-Weekly, which focuses on clinical quality, infection control, patient safety and accreditation, click here.
Latest Articles
- 5 Areas That Trip Up ASCs During Accreditation Evaluations
- CMS Loosens Medicaid Enrollment Process
- Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
- Joint Commission Appoints Mark Pelletier COO, Division of Accreditation, Certification
- Johns Hopkins: Blood Transfusions Overused During Surgery
